Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan Hyde

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Gerontologist|December 17, 2008
Dementia and assisted livingJoan Hyde, Rosa Perez, Brent Forester
American Journal of Alzheimer'S Disease and Other Dementias|February 11, 2014
The Impact of Enhanced Programming on Aging in Place for People With Dementia in Assisted LivingJoan Hyde, Rosa Perez, Patrick J Doyle, et al.
The Gerontologist|October 23, 2003
Environmental correlates to behavioral health outcomes in Alzheimer's special care unitsJohn Zeisel, Nina M Silverstein, Joan Hyde, et al.
The American Journal of Geriatric Pharmacotherapy|November 13, 2007
Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medicationBrent Forester, Mark Vanelli, Joan Hyde, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Gerontologist|December 17, 2008
Dementia and assisted livingJoan Hyde, Rosa Perez, Brent Forester
American Journal of Alzheimer'S Disease and Other Dementias|February 11, 2014
The Impact of Enhanced Programming on Aging in Place for People With Dementia in Assisted LivingJoan Hyde, Rosa Perez, Patrick J Doyle, et al.
The Gerontologist|October 23, 2003
Environmental correlates to behavioral health outcomes in Alzheimer's special care unitsJohn Zeisel, Nina M Silverstein, Joan Hyde, et al.
The American Journal of Geriatric Pharmacotherapy|November 13, 2007
Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medicationBrent Forester, Mark Vanelli, Joan Hyde, et al.
Pageof 1